G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2011
11/15/2011	US8057800 antiallergens; antibody for patient hypersensitive to peanuts or tree nuts; isolated peptide comprising an Ara h 2 T cell epitope; diagnosing or monitoring the allergenic condition in a mammal
11/15/2011	US8057761 Detecting nerve agents and determining the types thereof
11/15/2011	US8057759 Microfluidic system and apparatus and method of controlling the same
11/15/2011	US8057754 Apparatus and method for tip alignment in multiwell plates
11/15/2011	US8057753 Test strip ejection mechanism
11/15/2011	US8057752 Fluid analyzer for determining fluid chemistry of formation fluid by downhole reagent injection spectral analysis
11/15/2011	US8057740 Medical biosensor by means of which biological liquids are analyzed
11/15/2011	US8057418 Devices and methods for extracorporeal ablation of circulating cells
11/15/2011	DE202011051623U1 Probengefäß zur Verwendung für die retrograde Mikroskopie mit eingebauter definierter Schärfenebene Sample container for use in the retrograde microscopy with built-defined focal plane
11/15/2011	CA2659640C Nanostructures for polarized imaging and receptor/ligand quantization: breaking the diffraction limit for imaging
11/15/2011	CA2638949C Methods of and apparatus for determining the viscosity of heavy oil
11/15/2011	CA2601780C Rapidly detecting and quantifying viable legionella with dip-slide
11/15/2011	CA2582088C Method and apparatus for obtaining blood for diagnostic tests
11/15/2011	CA2556577C Test element with a capillary for transport of a liquid sample
11/15/2011	CA2518569C Liquid tissue preparation from histopathologically processed biological samples, tissues and cells
11/15/2011	CA2517709C Methods for direct detection of individual methotrexate metabolites
11/15/2011	CA2508468C Nucleosides or nucleotides having novel unnatural bases and use thereof
11/15/2011	CA2476166C Anti-cd20 antibodies and fusion proteins thereof and methods of use
11/15/2011	CA2473735C Self-calibrating carbon monoxide detector and method
11/15/2011	CA2450473C Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
11/15/2011	CA2422635C In vitro assay for measuring the immunogenicity of a vaccine
11/15/2011	CA2418793C Pharmaceutical composition comprising an analgesic peptide
11/15/2011	CA2405715C Methods for selective targeting
11/15/2011	CA2398526C Method for the evaluation of implantable materials
11/15/2011	CA2385652C Method and nucleic acids for the detection of microorganisms relevant to brewing
11/15/2011	CA2384510C Method of sequencing a nucleic acid
11/15/2011	CA2365196C Chlamydia antigens and corresponding dna fragments and uses thereof
11/15/2011	CA2359234C A method for labeled conjugate production
11/15/2011	CA2343979C Human interleukin-b50, therapeutic uses
11/15/2011	CA2257851C Modulators of tissue regeneration
11/15/2011	CA2189349C Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
11/15/2011	CA2171761C Eotaxin: eosinophil chemotactic cytokine
11/15/2011	CA2170641C Senescent cell-derived inhibitors of dna synthesis
11/13/2011	CA2793778A1 Biomarkers for p13k-driven cancer
11/10/2011	WO2011140555A2 Automated system to create a cell smear
11/10/2011	WO2011140476A1 Device, system and method for transit testing of samples
11/10/2011	WO2011140391A2 Egfr-related polypeptides and methods of use
11/10/2011	WO2011140270A2 Methods and systems for ultra-trace analysis of liquids
11/10/2011	WO2011140241A2 Methods and compositions for preserving tissues and organs
11/10/2011	WO2011140234A1 Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
11/10/2011	WO2011140215A2 Lanthionine synthetase component c-like proteins as molecular targets for preventing and treating diseases and disorders
11/10/2011	WO2011140173A1 Detection and treatment of fibrosis
11/10/2011	WO2011140169A1 Serial analysis of biomarkers for disease diagnosis
11/10/2011	WO2011140125A1 Methods of characterizing host responsiveness to interferon by ex vivo induction of interferon-responsive markers
11/10/2011	WO2011140093A2 Detection and monitoring of nonalcoholic fatty liver disease
11/10/2011	WO2011140042A1 Method for hematology analysis
11/10/2011	WO2011140030A2 System and method for measuring the ratio of forward-propagating to back-propagating second harmonic-generation signal, and applications thereof
11/10/2011	WO2011139998A2 Electrochemical sensor system
11/10/2011	WO2011139993A2 Screening methods, compositions identified thereby, tools useful for the identification thereof, and cell populations produced thereby
11/10/2011	WO2011139985A1 Compositions and methods for the diagnosis and treatment of tumor
11/10/2011	WO2011139972A2 Apparatus, method and system for generating optical radiation from biological gain media
11/10/2011	WO2011139914A1 Metabolic biomarkers of autism
11/10/2011	WO2011139854A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
11/10/2011	WO2011139853A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
11/10/2011	WO2011139792A2 Antibody-nanoparticle conjugates and methods for making and using such conjugates
11/10/2011	WO2011139773A1 Plasma biomarkers of cognitive impairment in parkinson's disease
11/10/2011	WO2011139750A1 Rapid genotyping analysis for human papillomavirus and the device thereof
11/10/2011	WO2011139733A2 Immune and oxygen system measuring and drug screening method and apparatus
11/10/2011	WO2011139721A1 Cancer biomarkers and methods of use thereof
11/10/2011	WO2011139681A1 Assays for anti-drug antibodies in the presence of abundant endogenous protein counterpart of the drug
11/10/2011	WO2011139634A1 Processes and kits for determining multi-drug resistance of cells
11/10/2011	WO2011139629A2 Light targeting molecules and uses thereof
11/10/2011	WO2011139372A1 Sequence analysis of complex amplicons
11/10/2011	WO2011139371A1 Monitoring health and disease status using clonotype profiles
11/10/2011	WO2011139344A2 Nanoscale apertures having islands of functionality
11/10/2011	WO2011139275A1 Method of detecting nerve agents using novel assay agents
11/10/2011	WO2011139245A1 A method and composition for quantifying magnesium ions
11/10/2011	WO2011139106A2 Method for diagnosis of dementia by measuring concentration of pgcp in plasma
11/10/2011	WO2011138985A1 Capacitive element sensor and method for manufacturing same
11/10/2011	WO2011138955A1 METHOD OF ANALYSIS FOR MUCIN 1 HAVING SUGAR CHAIN OF Siaα2-8Siaα2-3Galβ-R
11/10/2011	WO2011138778A2 Methods of identifying inhibitors of polypeptides-of-interest
11/10/2011	WO2011138757A1 Peptide derivatives for biofunctionalization of silicon substrates and their applications
11/10/2011	WO2011138705A2 Sensing device for detecting a substance in a fluid
11/10/2011	WO2011138641A1 A construct comprising a ni and/or au substrate
11/10/2011	WO2011138629A1 Remotely controlled semi-automatic mechanized sampling and temperature measuring probe apparatus for molten steel in metallurgical furnaces
11/10/2011	WO2011138592A2 Devices and mehtods for testing analytes
11/10/2011	WO2011138578A1 Vcjd confirmatory screening assay
11/10/2011	WO2011138561A1 METHOD FOR MEASURING IgG-MEDIATED COMPLEMENT ACTIVATION
11/10/2011	WO2011138509A1 Method and arrangement in connection with a measuring device
11/10/2011	WO2011138506A1 Flow cytometric method for distinguishing between bacterial and viral infections
11/10/2011	WO2011138462A1 Diagnostic method for the detection of cells ex vivo
11/10/2011	WO2011138456A1 Methods to identify modulators of tas2r4s receptors
11/10/2011	WO2011138455A1 Methods to identify modulators
11/10/2011	WO2011138454A1 Novel factors that promote triplet repeat expansions
11/10/2011	WO2011138423A1 Chimeric receptors and methods for identifying agents exhibiting an activity on type 1 single pass transmembrane receptors
11/10/2011	WO2011138419A1 Lipidomic biomarkers for atherosclerosis and cardiovascular disease
11/10/2011	WO2011138414A1 Methods and tools for screening agents exhibiting an activity on receptors of the tumor necrosis factor receptor superfamily
11/10/2011	WO2011138269A1 Hyperpolarized lactate contrast agent for determination of ldh activity
11/10/2011	WO2011137906A1 Test for male fertility
11/10/2011	WO2011137902A1 Hyperthermia augmented in-vitro immune recognition
11/10/2011	WO2011137574A1 Fluoride-boron dye fluorescent probe for detecting mercury ion
11/10/2011	WO2011137554A1 Method and apparatus for measuring the weight of impurities in a mixed volume of fibers and impurities
11/10/2011	WO2011137553A1 Apparatus and method for measuring the weight of impurities in a mixed volume of fibers and impurities
11/10/2011	WO2011137552A1 Visual weight compensation
11/10/2011	WO2011137540A1 Gfi1b modulation and uses thereof
11/10/2011	WO2011137519A1 Methods and compositions for the diagnosis and treatment of thyroid cancer
11/10/2011	WO2011137513A1 Method for the diagnosis of epithelial cancers by the detection of epicd polypeptide
11/10/2011	WO2011137486A1 Diagnostic and prognostic and therapeutic methods
11/10/2011	WO2011115840A3 Parasite detection via endosymbiont detection
11/10/2011	WO2011113942A3 Method for predicting the responsiveness to chemotherapy

1 ... 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 ... 3937